Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-18

Clinical Trial Update: The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS) [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase trial evaluating the effect of adding α-galactosidase during a carbohydrate-rich meal in adults with irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • α-galactosidase (alpha-galactosidase)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Irritable Bowel Syndrome | EARLY_Phase 1 | Status: COMPLETED